Αποτελέσματα Αναζήτησης
14 Νοε 2024 · Diamyd Medical is a Swedish diabetes company active in the field of pharmaceutical development, dedicated to finding a cure for autoimmune diabetes. The share is listed on Nasdaq First North Growth Market (ticker: DMYD B)
Diamyd Medical is a Swedish clinical-stage diabetes company active in the field of pharmaceutical development. The share is listed on Nasdaq Stockholm First North (ticker: DMYD B).
Diamyd Medical is dedicated to finding a way to prevent, treat and cure autoimmune diabetes. Antibodies and Autoimmune Diabetes The immune system’s attack on the beta cells starts long before clinical symptoms of type 1 diabetes have appeared, but can be detected in the bloodstream before diagnosis by testing for the presence of certain ...
Diamyd Medical has 5 employees across 2 locations and kr546 k in annual revenue in FY 2023. See insights on Diamyd Medical including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.
Company profile page for Diamyd Inc including stock price, company news, executives, board members, and contact information
View Diamyd Medical (www.diamyd.com) location in Stockholm, Sweden , revenue, industry and description. Find related and similar companies as well as employees by title and much more.
Diamyd Medical is a Swedish diabetes company developing precision medicine therapies for Type 1 Diabetes. The therapeutic diabetes vaccine Diamyd , an antigen-specific immunotherapy for the...
